Pediatric Neurology

Treatment and Care for Children

 Coronavirus infection can affect children of all ages in 2019 (COVID-19). However, most infected children do not get as sick as adults, and some may not show any symptoms. Due to the lack of specificity of signs and symptoms, as well as the large number of asymptomatic infections, symptom-based screening for SARS-CoV-2 in children is particularly difficult. For children with severe or critical COVID-19, supportive care (e.g., respiratory assistance, hydration and electrolyte support, and monitoring of cytokine release syndrome) are the foundation of treatment. For the majority of COVID-19 vaccinations being only authorized for adults over the age of 18, an increasing number of vaccines are being approved for use in young people. MRNA vaccines for use in the adolescent age group have obtained emergency use authorization in some countries (ages 12-17). Two inactivated vaccines (Sinovac-CoronaVac and BBIBP-CorV) have completed trials on children as young as three, and these products have been licensed by the Chinese authorities for ages three to seventeen.